Ann Dermatol.  2009 Feb;21(1):42-45. 10.5021/ad.2009.21.1.42.

Aneurysmal Benign Fibrous Histiocytoma with Atrophic Features

Affiliations
  • 1Department of Dermatology, Seoul National University College of Medicine, Boramae Medical Center, Seoul, Korea. sycho@snu.ac.kr
  • 2Department of Pathology, Seoul National University College of Medicine, Boramae Medical Center, Seoul, Korea.
  • 3Department of Plastic Surgery, Seoul National University College of Medicine, Boramae Medical Center, Seoul, Korea.

Abstract

Aneurysmal benign fibrous histiocytoma is an uncommon pathologic variant of dermatofibroma. In addition to the features of a typical dermatofibroma, it has large cleft-like or cavernous blood-filled spaces with numerous hemosiderin pigments. It should be differentiated from angiomatoid malignant fibrous histiocytoma, malignant melanoma, and vascular tumors such as Kaposi's sarcoma and angiosarcoma. Atrophic dermatofibroma is also a rare variant of dermatofibroma, and the combination of aneurysmal and atrophic features is rarer still. We report a case of aneurysmal benign fibrous histiocytoma with atrophic features in a 27-year-old male who had a grayish-brown atrophic patchy lesion on his back for 2 years.

Keyword

Aneurysmal variant; Atrophy; Dermatofibroma

MeSH Terms

Adult
Aneurysm
Atrophy
Caves
Hemangiosarcoma
Hemosiderin
Histiocytoma, Benign Fibrous
Histiocytoma, Malignant Fibrous
Humans
Male
Melanoma
Sarcoma, Kaposi
Hemosiderin

Figure

  • Fig. 1 A non-tender, fingernail-sized, grayish-brown, atrophic, shiny patch on the upper back.

  • Fig. 2 (A) Histopathological findings revealed a non-encapsulated, ill-defined mass with numerous large pigments in the dermis without significant epidermal changes (H&E, ×40). (B) Multiple cavernous angiomatoid areas were surrounded by histiocytes, fibroblasts, pigments, and capillaries. Extravasated red blood cells and multinucleated giant cells were also observed (H&E, ×200).

  • Fig. 3 The large pigments in tumor mass were positively stained for iron (Prussian blue, ×200).

  • Fig. 4 (A) Immunohistochemical staining was performed using the avidin-biotin complex method. Most of the tumor cells are strongly positive for vimentin (×200). (B) Endothelial cells lining the cavernous spaces and tumor cells focally stain for CD34. However, the majority of tumor cells are negative for DC34 (×100).


Reference

1. Santa Cruz DJ, Kyriakos M. Aneurysmal ("angiomatoid") fibrous histiocytoma of the skin. Cancer. 1981. 47:2053–2061.
Article
2. Calonje E, Fletcher CD. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 1995. 26:323–331.
Article
3. Goldblum JR, Tuthill RJ. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol. 1997. 19:147–153.
Article
4. Zelger BW, Zelger BG, Steiner H, Ofner D. Aneurysmal and haemangiopericytoma-like fibrous histiocytoma. J Clin Pathol. 1996. 49:313–318.
Article
5. Page EH, Assaad DM. Atrophic dermatofibroma and dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1987. 17:947–950.
Article
6. Curco N, Pagerols X, Garcia M, Tarroch X, Vives P. Atrophic dermatofibroma accompanied by aneurysmatic characteristics. J Eur Acad Dermatol Venereol. 2006. 20:331–333.
Article
7. Zelger BW, Ofner D, Zelger BG. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Histopathology. 1995. 26:519–527.
Article
8. Kiyohara T, Kumakiri M, Kobayashi H, Ohkawara A, Lao LM. Atrophic dermatofibroma. Elastophagocytosis by the tumor cells. J Cutan Pathol. 2000. 27:312–315.
Article
9. Beer M, Eckert F, Schmoeckel C. The atrophic dermatofibroma. J Am Acad Dermatol. 1991. 25:1081–1082.
Article
10. Kim EH, Kang HY, Lee ES, Kim YC. Two cases of dermatofibroma with atrophic features. Korean J Dermatol. 2007. 45:305–308.
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr